Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
| NAV as of Dec 04, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
|---|---|---|---|
| ₹9.5811+0.22% 1 day change | -4.29% | App exclusive | ₹621 Cr |
| AUM (Fund size) | ₹621 Cr |
| Exit load | 1.0% Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.! |
| Lock-in Period | Nil |
| Age | 6 m since Jun 09, 2025 |
| Benchmark | BSE Healthcare TRI |
| Min. investment | SIP: ₹1000 & Lumpsum: ₹5000 |
| Expense ratio | 2.28% as on Nov 30, 2025 |
| Plan type | Regular |
| Risk | Very High |
| Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
| Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
| Period | This fund | Category average |
|---|---|---|
| 1 Month | -1.65% | -0.5% |
| 3 Months | -2.02% | -0.18% |

Large Cap 48.25%
Mid Cap 17.64%
Small Cap 29.64%
Other Cap 0%
Healthcare 92.77%
Insurance 2.76%
Bifurcation by Credit Quality is not available for this fund
Others 4.73%
CBLO 4.73%
Bifurcation by Holding is not available for this fund

| Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | -1.65% | N.A. | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -1.23% | 4.82% | 3.39% | 26.7% | 18.92% | 15.06% |
| SBI Healthcare Opportunities Fund | -1.1% | 3.97% | 0.86% | 23.76% | 18.07% | 11.44% |
| DSP Healthcare Fund | -0.08% | 4.88% | -4.97% | 20.67% | 16.37% | 14.69% |
| Tata India Pharma & Healthcare Fund | -1.43% | 4.98% | -0.15% | 21.51% | 16.34% | 11.83% |
| Nippon India Pharma Fund | -0.66% | 2.62% | -0.17% | 21.01% | 16.31% | 13.46% |
| Fund name | Std. deviation | Beta | Sharpe | Sortino |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | N.A. | N.A. | N.A. | N.A. |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.69 | 0.95 | 1.21 | 1.78 |
| SBI Healthcare Opportunities Fund | 14.09 | 0.85 | 1.16 | 1.86 |
| DSP Healthcare Fund | 14.58 | 0.84 | 0.96 | 1.68 |
| Tata India Pharma & Healthcare Fund | 16.04 | 0.97 | 0.92 | 1.47 |
| Nippon India Pharma Fund | 15.23 | 0.91 | 0.94 | 1.42 |
| Fund name | ETM Rank | AUM | Fund age | Expense ratio |
|---|---|---|---|---|
| Baroda BNP Paribas Health and Wellness Fund | N.A. | 621 Cr | 6 m | 2.28% |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,437 Cr | 7 yrs 5 m | 1.86% |
| SBI Healthcare Opportunities Fund | N.A. | 4,082 Cr | 26 yrs 6 m | 1.93% |
| DSP Healthcare Fund | N.A. | 3,144 Cr | 7 yrs 1 m | 1.91% |
| Tata India Pharma & Healthcare Fund | N.A. | 1,325 Cr | 10 yrs | 2.1% |
| Nippon India Pharma Fund | N.A. | 8,346 Cr | 21 yrs 7 m | 1.81% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
| Fund AUM | 621 Cr as on Oct 31, 2025 |
| Scheme document | View Scheme Document |
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
| No. of schemes | 41 view all schemes |
| Total AUM | 50,753 Cr as on Sep 30, 2025 |
| Address | BNP Paribas House, 7th Floor, G-Block, Bandra Kurla Complex, Bandra Mumbai, 400051 |
| Phone | 022-33704000 |
| Fund name | ETM Rank | AUM | 1Y | 5Y |
|---|---|---|---|---|
| Baroda BNP Paribas Midcap Fund | N.A. | 2,276 Cr | 2.54% | 21.97% |
| Baroda BNP Paribas Multi Cap Fund | N.A. | 3,108 Cr | -2.44% | 20.6% |
| Baroda BNP Paribas Large & Mid Cap Fund | N.A. | 1,697 Cr | -1.13% | 19.54% |
| Baroda BNP Paribas India Consumption Fund | N.A. | 1,552 Cr | 0.14% | 17.51% |
| Baroda BNP Paribas ELSS Tax Saver Fund | N.A. | 935 Cr | 3.41% | 16.8% |
| Baroda BNP Paribas Large Cap Fund | N.A. | 2,729 Cr | 2.24% | 16.24% |
The current Net Asset Value (NAV) of the Baroda BNP Paribas Health and Wellness Fund plan is approximately ₹9.5811 as of Dec 04, 2025.
The Baroda BNP Paribas Health and Wellness Fund has an expense ratio of 2.28%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Baroda BNP Paribas Health and Wellness Fund currently has assets under management (AUM) or fund size valued at approximately 621 Cr as on Oct 31, 2025.
The Baroda BNP Paribas Health and Wellness Fund has invested the majority of its money in the stocks of the following companies -
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 9.25% |
| Mankind Pharma Ltd. | 7.29% |
| Divi's Laboratories Ltd. | 7.05% |
| Apollo Hospitals Enterprise Ltd. | 6.18% |
| Max Healthcare Institute Ltd. | 5.54% |
| Cipla Ltd. | 5.38% |
| Aster DM Healthcare Ltd. | 4.91% |
| Abbott India Ltd. | 4.57% |
| Astrazeneca Pharma India Ltd. | 4.0% |
| Gland Pharma Ltd. | 3.73% |
The Baroda BNP Paribas Health and Wellness Fund has primarily invested in the following sectors
| Sector | Percentage of Portfolio |
|---|---|
| Healthcare | 92.77% |
| Insurance | 2.76% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the Baroda BNP Paribas Health and Wellness Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.
